Applied Therapeutics Inc [APLT] stock is trading at $0.49, up 10.25%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The APLT shares have gain 15.52% over the last week, with a monthly amount glided 31.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Applied Therapeutics Inc [NASDAQ: APLT] stock has seen the most recent analyst activity on December 23, 2024, when William Blair downgraded its rating to a Mkt Perform. Previously, UBS downgraded its rating to Neutral on December 02, 2024, and dropped its price target to $2. On November 29, 2024, downgrade downgraded it’s rating to Sector Perform and revised its price target to $4 on the stock. William Blair started tracking the stock assigning a Outperform rating. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $12 as its price target on March 26, 2024. Leerink Partners started tracking with a Outperform rating for this stock on February 22, 2024, and assigned it a price target of $12. In a note dated January 04, 2022, Barclays downgraded an Equal Weight rating on this stock and revised its target price from $44 to $7.
Applied Therapeutics Inc [APLT] stock has fluctuated between $0.29 and $10.62 over the past year. Currently, Wall Street analysts expect the stock to reach $4.5 within the next 12 months. Applied Therapeutics Inc [NASDAQ: APLT] shares were valued at $0.49 at the most recent close of the market. An investor can expect a potential return of 818.37% based on the average APLT price forecast.
Analyzing the APLT fundamentals
Applied Therapeutics Inc [NASDAQ:APLT] reported sales of 0.27M for the trailing twelve months, which represents a drop of -100.00%. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -228.72%, Pretax Profit Margin comes in at -231.63%, and Net Profit Margin reading is -231.63%. To continue investigating profitability, this company’s Return on Assets is posted at -1.22, Equity is -2.09 and Total Capital is -1.76. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4448 points at the first support level, and at 0.4044 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5087, and for the 2nd resistance point, it is at 0.5322.
Ratios To Look Out For
For context, Applied Therapeutics Inc’s Current Ratio is 3.00. In addition, the Quick Ratio stands at 3.00 and the Cash Ratio stands at 2.91. Considering the valuation of this stock, the price to sales ratio is 254.41, the price to book ratio is 1.87.
Transactions by insiders
Recent insider trading involved Perfetti Riccardo, Chief Medical Officer, that happened on Mar 04 ’25 when 10366.0 shares were sold., Funtleyder Leslie D. completed a deal on Mar 04 ’25 to sell 14502.0 shares. Meanwhile, Chinoporos Constantine sold 447.0 shares on Mar 04 ’25.
